← FDA DRUG APPROVALS

FDA ANDA · ANDA076427

MILRINONE LACTATE

Sponsor: BAXTER HLTHCARE CORP

APPLICATION
ANDA076427
TYPE
ANDA
ORIGINAL APPROVAL
2004-09-21
LATEST ACTION
2006-06-27
ROUTE
INJECTION
DOSAGE FORM
INJECTABLE
MARKETING STATUS
Prescription, Discontinued

Products

MILRINONE LACTATEPrescription
MILRINONE LACTATE 20MG/20ML · INJECTABLE · INJECTION
MILRINONE LACTATEDiscontinued
MILRINONE LACTATE EQ 1MG BASE/ML · INJECTABLE · INJECTION

Approval history

2006-06-27Labeling · Supplement 8AP
2004-09-21OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industryGMP disciplineFDA drug shortagesFDA enforcement & recalls

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →